2m 2m 2m 2m 2m 2m 2m
Eli Lilly & Co (LLY)
NYSE
$1,148.80-$0.04 (-0.004%)
Price as of Jul 31, 2026 8:00 PM EDT- $1.0TMarket Cap
- 51.77%1-Year Change
- Drug Manufacturers - GeneralIndustry
Eli Lilly & Co (LLY)
$1,148.80-$0.04 (-0.004%)
LLY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1,148.84 | ||
Change | -$6.13 (-0.53%) | ||
Open | $1,148.51 | ||
High | $1,150.63 | ||
Low | $1,119.00 | ||
Previous Close | $1,154.97 | ||
Volume | 2,884,624 | ||
30-Day Average Volume | 2,412,640 | ||
1-Week Change | -3.95% | ||
1-Month Change | -4.22% | ||
1-Year Change | 51.77% | ||
3-Year Change | 158.19% | ||
5-Year Change | 394.60% | ||
Fundamentals | |||
Shares Outstanding | 891.7M | ||
Total Assets | $116.6B | ||
Market Cap | $1.0T | ||
Enterprise Value | $1.1T | ||
Period: QTR TTM FY | |||
Revenue | $19.8B | ||
Net Income | $7.4B | ||
Free Cash Flow | $5.3B | ||
EBIT | $8.8B | ||
EBITDA | $9.4B | ||
Net Working Capital | $18.2B | ||
EPS | $8.26 | ||
Enterprise Value/EBITDA | 114 | ||
Enterprise Value/Revenue | 54 | ||
P/B | 33 | ||
P/E | 139 | ||
PEG | 12 | ||
Price/Free Cash Flow | 192 | ||
Price/Operating Cash Flow | 192 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.60% | ||
Trailing Annual Dividend Yield | 0.56% | ||
Ex-Dividend Date | 08/14/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield